Acute Myeloid Leukemia

Videos

Dr Koehne Talks Hot Topics in Hematology at the Miami Cancer Institute Summit

03/22/2021

Guenther Koehne, MD, discusses highlights from the Second Summit of the Americas on Immunotherapy for Hematologic Malignancies.

Guenther Koehne, MD, discusses...

03/22/2021

Oncology

Conference Insider

Exploring Dosing Regimens of Sabatolimab Therapy for MDS/AML

12/14/2020

Study findings support further exploration of specific dosing regimens of sabatolimab in patients with intermediate- to very high-risk MDS/AML.

Study findings support further...

12/14/2020

Oncology

News

Ruxolitinib Plus Azacitidine Tolerable for Advanced Phase MPN, Post-MPN AML

12/02/2020

Ruxolitinib combined with azacitidine was a well-tolerated therapy option for patients with advanced phase MPN and post-MPN AML.

Ruxolitinib combined with...

12/02/2020

Oncology

Videos

Mary-Beth Percival, MD, Talks Caring for AML Patients Amid a National Pandemic

10/01/2020

Dr Percival discusses the provision of care to patients with AML during the COVID-19 pandemic.

Dr Percival discusses the...

10/01/2020

Oncology

Conference Insider

Challenges and New Horizons in the Treatment of Patients With AML

07/17/2020

During the Great Debates & Updates in Hematologic Malignancies, Gail Roboz, MD, discussed how clinicians can lead patients with AML down the correct treatment path.

During the Great Debates &...

07/17/2020

Oncology

Videos

Novel Therapies in AML

10/24/2019

Gail Roboz, MD, summarizes her presentation about novel therapies in AML at the 2019 Lymphoma & Myeloma Congress.

Gail Roboz, MD, summarizes her...

10/24/2019

Oncology

Videos

Alternative Treatment Options for Older Patients With AML

10/23/2019

Sangmin Lee, MD, argued that venetoclax plus azacitidine, decitabine, and LDAC should not be the new standard care for older patients with AML.

Sangmin Lee, MD, argued that...

10/23/2019

Oncology

Videos

Influx of New Therapies Exciting for Future of AML Treatment

03/23/2019

Daniel A. Pollyea, MD, MS, discusses all the recent drug approvals in AML and how they are changing clinical practice.

Daniel A. Pollyea, MD, MS,...

03/23/2019

Oncology

Podcasts

Early Results Show Promise With Venetoclax-Idasanutlin Combo for Relapsed/Refractory AML

12/20/2018

Gail Roboz, MD, discusses a recent trial involving the combination of venetoclax plus idasanutlin for patients with relapsed or refractory AML.

Gail Roboz, MD, discusses a...

12/20/2018

Oncology

Podcasts

Extended Decitabine Dosing Schedule Provides No Benefit Over Shorter Regimen in Newly Diagnosed AML

12/20/2018

Guillermo Garcia‑Manero, MD, discussed the clinical significance and potential implications of using a 5- versus 10-day decitabine dose schedule in patients with newly diagnosed AML.

Guillermo Garcia‑Manero, MD,...

12/20/2018

Oncology